Coronavirus disease 2019 (COVID-19) is an emerging infectious disease. Bilateral
pneumonia, acute respiratory failure, systemic inflammation, endothelial dysfunction and …

2 METHODS This guidance statement is a collaborative effort of the Perioperative and
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …

Comment www. thelancet. com/haematology Vol 7 May 2020 e363 risk factors (aged 40
years or older, had hepatic failure (international normalised ratio> 1∙ 5), had severe renal …

Background High incidence of venous thromboembolic complications in coronavirus
disease 2019 (COVID-19) patients was noted recently. Objective This study aimed to …

Patients who are admitted to the hospital with coronavirus disease 2019 (Covid-19) are at
high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of …

Despite the emergence of high quality randomized trial data with the use of antithrombotic
agents to reduce the risk of thromboembolism, end‐organ failure, and possibly mortality in …

Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

The novel coronavirus, SARS-CoV-2, is causing a global pandemic of life-threatening
multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with …

The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being
comprehended. A high number of thrombotic episodes are reported, along with the mortality …

Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …